Making Clinical Trials More Accessible to All
Nov 13, 2021 2:00 PM (ET)
Clinical trials should embrace health equity, not serve as a barrier to it. In this session, we will hear how industry sponsors are approaching clinical trials with a move towards ensuring diverse representation, inclusion of patient voice, and how technology is enabling more access to patient research. We will leave this session with a better understanding of how trial sponsors are bringing the clinical trial journey to patients’ doorsteps.
Speakers
Patricia “Patti” M. Doykos (she/her), PhD
View Bio
Patricia “Patti” M. Doykos (she/her), PhD
Executive Director of Healthy Equity, Bristol Myers Squibb
Patti leads internal and external health equity efforts across BMS, bringing particular focus to medically underserved patients and communities.
Patti has 23 years of experience and leadership in transformative corporate philanthropy and corporate social responsibility, product brand and strategic communications, and health equity and social justice at BMS. Most recently, she served as Senior Director of the Bristol Myers Squibb Foundation since 2002. In January 2020, she took on the role of lead for BMS’s Health Equity Initiative to develop and implement an enterprise-wide health equity approach and strategy. Previously, Patti has developed and led U.S. and international grant-making and public-private partnership programs for global HIV/AIDS, women’s health, diabetes, serious mental illness, cancer, immunology, and COVID-19.
Among her current service roles are inaugural chair of the board of the Center for Global Health Equity at Dartmouth-Geisel Medical School, Board of Advisors for Dartmouth-Geisel Medical School, Advisory Board of the Center for Global Health at Rutgers University, and Trustee of Phillips Academy Andover and member of its Anti-Racism Task Force.
Patti holds a B.A. from Dartmouth College for majors in Government and German, an M.A. in German Literature & Language from the University of Virginia, and a Ph.D. in the same from New York University, both with a concentration in Cultural Studies.
Cathy Florek (she/her)
View Bio
Cathy Florek (she/her)
Director, Head of Engagement Strategy, Bristol Myers Squibb
Cathy has been with BMS for over 30 years, spending the majority of her time in research and development. She currently leads a team of engagement strategy leads within the global development operations division of BMS. The engagement strategy team focuses on bringing the voice of the patients and caregivers into our trial designs and implementation, with a goal to drive meaningful change, improve experience, and generate greater patient diversity in our clinical trials.
Tiffany Lynn Valentine (she/her), MBA, PMP, CSM
View Bio
Tiffany Lynn Valentine (she/her), MBA, PMP, CSM
Associate Director Clinical Innovation Lead, Bristol Myers Squibb
Tiffany has 25 years of pharmaceutical experience managing local and global clinical trials, developing and launching digital projects, innovation campaigns, and industry consortia workstreams. She is responsible for running and implementing new clinical innovation and digital opportunities to improve BMS Global Clinical Operations, enabling BMS to become an industry leader in light of clinical innovation. Tiffany drives the implementation of prototypes, proof of concepts, and pilots to delivery innovative clinical development and clinical operations opportunities.